Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 386184016 | Pancreatic lipase | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| 650855015 | Pancreatic lipase (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | IPS terminology module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pancreatic lipase | Is a | Pancreatic enzyme (substance) | true | Inferred relationship | Some | ||
| Pancreatic lipase | Is a | Triacylglycerol lipase | true | Inferred relationship | Some | ||
| Pancreatic lipase | Has disposition (attribute) | Hydrolase (disposition) | true | Inferred relationship | Some | ||
| Pancreatic lipase | Has disposition (attribute) | Pancreatic enzyme (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | True | Pancreatic lipase | Inferred relationship | Some | 2 |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Pancreatic lipase | Inferred relationship | Some | 2 |
This concept is not in any reference sets
FHIR